GigaMune is a company headquartered in the United States.
GigaMune is a San Francisco-based biotechnology company developing in vivo cell therapies for cancer and inherited blood disorders by delivering viral gene therapy vectors directly into patients to overcome manufacturing bottlenecks of current cell therapies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.